SAMANTHA WAITZMAN: Open Payments
NPI 1457878225 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 24 payments from 12 companies in 2025. Trend: 2023 $859 · 2024 $1,214 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $156 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $34 |
| Galderma Laboratories, L.P. | 2 | $33 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $33 |
| GENZYME CORPORATION | 1 | $31 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $19 |
| Journey Medical Corporation | 1 | $18 |
| Organon LLC | 1 | $18 |
Products named: SKYRIZI, DUPIXENT, BLU-U, NEMLUVIO, Zoryve, RINVOQ, Otezla, TREMFYA.
Industry payments across IL — which companies pay providers there.
